[Systemic mastocytosis].
Sökler
Martin
M
Medizinische Klinik, Abteilung für Hämatologie, Onkologie, Rheumatologie, Immunologie und Pulmologie, Otfried-Müller-Strasse 10, 72076 Tübingen.
Kanz
Lothar
L
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001549:Benzamides; D017338:Cladribine / Q000627:therapeutic use; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D034721:Mastocytosis, Systemic / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D001549:Benzamides; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D017338:Cladribine; D000068877:Imatinib Mesylate; D011239:Prednisolone; D011505:Protein-Tyrosine Kinases